NO963971D0 - Gel for behandling av hudsykdommer og for desinfisering av huden - Google Patents

Gel for behandling av hudsykdommer og for desinfisering av huden

Info

Publication number
NO963971D0
NO963971D0 NO963971A NO963971A NO963971D0 NO 963971 D0 NO963971 D0 NO 963971D0 NO 963971 A NO963971 A NO 963971A NO 963971 A NO963971 A NO 963971A NO 963971 D0 NO963971 D0 NO 963971D0
Authority
NO
Norway
Prior art keywords
gel
skin
alcohol
disinfecting
gives
Prior art date
Application number
NO963971A
Other languages
English (en)
Other versions
NO314126B1 (no
NO963971L (no
Inventor
John Brown Thomsen
Jens Christian Moeller
Original Assignee
John Brown Thomsen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Brown Thomsen filed Critical John Brown Thomsen
Publication of NO963971D0 publication Critical patent/NO963971D0/no
Publication of NO963971L publication Critical patent/NO963971L/no
Publication of NO314126B1 publication Critical patent/NO314126B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
NO19963971A 1994-03-21 1996-09-20 Farmasöytisk preparat i gelform for behandling av hudsykdommer og for desinfisering av huden, samt anvendelse av en kombinasjon av et polymer-geldannelsesmiddels og en lavere alkanol ved fremstilling av et preparat oganvendelse av enlavere alk NO314126B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK32594 1994-03-21
PCT/EP1995/001025 WO1995025544A1 (en) 1994-03-21 1995-03-20 Gel for treatment of skin diseases and for disinfection of the skin

Publications (3)

Publication Number Publication Date
NO963971D0 true NO963971D0 (no) 1996-09-20
NO963971L NO963971L (no) 1996-11-19
NO314126B1 NO314126B1 (no) 2003-02-03

Family

ID=8092278

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19963971A NO314126B1 (no) 1994-03-21 1996-09-20 Farmasöytisk preparat i gelform for behandling av hudsykdommer og for desinfisering av huden, samt anvendelse av en kombinasjon av et polymer-geldannelsesmiddels og en lavere alkanol ved fremstilling av et preparat oganvendelse av enlavere alk

Country Status (26)

Country Link
US (4) US5981605A (no)
EP (1) EP0751789B1 (no)
JP (1) JP3560977B2 (no)
KR (1) KR100396278B1 (no)
CN (1) CN1146725A (no)
AT (1) ATE208212T1 (no)
AU (1) AU701872B2 (no)
BR (1) BR9507164A (no)
CA (1) CA2186045A1 (no)
CZ (2) CZ286758B6 (no)
DE (1) DE69523745T2 (no)
DK (1) DK0751789T3 (no)
EE (1) EE03293B1 (no)
ES (1) ES2168111T3 (no)
FI (1) FI963696A (no)
HU (1) HUP9774641A2 (no)
LV (1) LV12951B (no)
MX (1) MX9604208A (no)
NO (1) NO314126B1 (no)
NZ (1) NZ283135A (no)
PL (1) PL179918B1 (no)
PT (1) PT751789E (no)
RU (1) RU2142273C1 (no)
SK (1) SK281575B6 (no)
UA (1) UA41989C2 (no)
WO (1) WO1995025544A1 (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT751789E (pt) * 1994-03-21 2002-04-29 Aase Brown Thomsen Gel para o tratamento de doencas da pele e para desinfeccao da pele
US6416760B2 (en) * 1995-01-26 2002-07-09 Societe L'oreal Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin
FR2732221B1 (fr) * 1995-03-28 1997-04-25 Oreal Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue
DE19624508A1 (de) * 1996-06-19 1998-01-08 Guetter Hans Peter Dr Verwendung von C¶3¶-C¶4¶-Alkoholen zur Behandlung von Herpeserkrankungen
NZ333872A (en) 1996-06-24 2000-08-25 Bio Safe Entpr Inc Barrier forming antibacterial composition comprising polyvinylpyrrolidone, hydroxyethylcellulonse, an antibacterial agent and an emulsifier
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
CN1452629A (zh) * 2000-05-31 2003-10-29 科学技术振兴事业团 含有人参皂甙Rb1的皮肤组织再生促进剂
AUPR028000A0 (en) * 2000-09-21 2000-10-12 Hair Advisory Centre Pty. Ltd. Ectoparasite formulation
US6581775B1 (en) * 2001-08-10 2003-06-24 Garo Hagopian Method of external genital cleansing and prophylactic kit
JP2005519868A (ja) * 2001-10-16 2005-07-07 アバニール・ファーマシューティカルズ ｎ−ドコサノールによるウイルス阻害
US20050042240A1 (en) * 2002-01-28 2005-02-24 Utterberg David S. High viscosity antibacterials
DE10219597A1 (de) * 2002-05-02 2003-11-20 Wella Ag Wasserfreie Haarstylinggele
JPWO2003105903A1 (ja) * 2002-06-18 2005-10-13 ポーラ化成工業株式会社 抗真菌医薬組成物
US20040191286A1 (en) * 2003-03-24 2004-09-30 Bijan Safai Head lice medication and treatment
GB0318160D0 (en) * 2003-08-02 2003-09-03 Ssl Int Plc Parasiticidal composition
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US20060024372A1 (en) * 2004-07-29 2006-02-02 Utterberg David S High viscosity antibacterials
US7268165B2 (en) * 2004-08-20 2007-09-11 Steris Inc. Enhanced activity alcohol-based antimicrobial compositions
US20070116749A1 (en) * 2005-11-21 2007-05-24 Grossman Leonard D Method for treatment of cellulitis
DE102005059742A1 (de) 2005-12-13 2007-06-14 Beiersdorf Ag Transparentes Sonnenschutzmittel
RS54764B1 (sr) 2006-07-21 2016-10-31 Biodelivery Sciences Int Inc Sredstvo za transmukozalnu isporuku sa povećanim nakupljanjem
WO2008049454A1 (en) 2006-10-23 2008-05-02 Ecolab Inc. Virucidal composition
US20100063004A1 (en) * 2006-12-04 2010-03-11 Ranjan Ray Chaudhuri Topical pharmaceutical composition
JP5028131B2 (ja) * 2007-04-13 2012-09-19 花王株式会社 ゲル化剤
WO2008137747A1 (en) 2007-05-02 2008-11-13 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
US20100247564A1 (en) * 2007-05-24 2010-09-30 David Yue-Wei Lee Methods and compositions for the use of sargassum fusiforme for the inhibition of hiv-1 infection
DE102008028993A1 (de) * 2007-06-29 2009-01-08 Bode Chemie Gmbh & Co. Kg Verwendung eines alkoholischen Desinfektionsmittels zur Schnelldesinfektion
EA013233B1 (ru) * 2008-06-12 2010-04-30 Иностранное Частное Унитарное Производственно-Торговое Предприятие "Инкраслав" Фирмы "Вера, О.О.О. Прешов" Антисептическая композиция для дезинфекции кожных покровов, способ ее приготовления и полупродукт для ее приготовления
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
EP2512231B1 (en) * 2009-12-16 2016-12-07 Ecolab Inc. Composition in form of a gel for the virucidal disinfection of mammalian skin
US10383894B2 (en) * 2010-03-17 2019-08-20 Lutran Industries, Inc. Human medicinal treatment using salt of peroxymonosulfuric acid
GB201010256D0 (en) * 2010-06-18 2010-07-21 Reckitt Benckiser Inc Germicidal topical compositions
FR2976808B1 (fr) * 2011-06-22 2013-06-28 Urgo Lab Composition filmogene et son utilisation pour le traitement de l'herpes
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US10071233B2 (en) * 2015-05-22 2018-09-11 L'oreal Point applicator for treating skin conditions
US10334853B2 (en) * 2016-03-29 2019-07-02 Larada Sciences Compositions and methods for treating ectoparasite infestation
US20220362166A1 (en) * 2019-10-25 2022-11-17 Mucocort Ab Treatment of inflammatory condition in mucous membrane or skin

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054989A (en) * 1933-12-30 1936-09-22 Us Ind Alcohol Co Compositions for application to the human skin
DE1000367B (de) 1952-11-17 1957-01-10 Mo Och Domsjoe Ab Verfahren zur Herstellung von in Wasser und/oder Alkali loeslichen Celluloseaethern
US3016328A (en) * 1961-01-03 1962-01-09 Ethicon Inc Dialdehyde alcoholic sporicidal composition
US4019521A (en) * 1973-06-06 1977-04-26 Philip Morris Incorporated Smokable material and method for preparing same
US3876771A (en) * 1973-09-04 1975-04-08 Hallister Inc Skin protective gel containing polyvinyl methylether or monoisopropyl ester of polyvinyl methylether maleic acid
GB1582744A (en) * 1976-06-04 1981-01-14 Gruenenthal Gmbh 7h-thiazolo (and 1,3,4-thiadiazolo-)(3,2-a) pyrimidin-7-one-5-carboxylic acids derivatives and medicaments therof
SE418686B (sv) * 1978-03-31 1981-06-22 Landstingens Inkopscentral Vattenbaserad salva for huddesinfektion innehallande alkohol som desinfektionsmedel
GB1593097A (en) * 1978-05-26 1981-07-15 Fisons Ltd Pharmaceutical compositions containing a bischromone
US4256872A (en) * 1978-09-26 1981-03-17 Occidental Research Corporation Process for preparing layered organophosphorus inorganic polymers
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment
US4590214A (en) * 1980-04-14 1986-05-20 Sepreh, Inc. Method of treatment for herpes
JPS5855411A (ja) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
US4431633A (en) * 1982-04-27 1984-02-14 Merck & Co., Inc. Influenza vaccine
DE3430709A1 (de) * 1984-08-21 1986-03-06 Krüger GmbH & Co KG, 5060 Bergisch Gladbach Viruzides mittel
US5288486A (en) * 1985-10-28 1994-02-22 Calgon Corporation Alcohol-based antimicrobial compositions
US4671955A (en) * 1986-03-31 1987-06-09 Victor Palinczar Waterproof sunscreen compositions
FR2613621B1 (fr) * 1987-04-10 1990-06-29 Roussel Uclaf Butyl hydroxyanisoles pour utilisation dans le traitement prophylactique des maladies a retro-virus comme agents modificateurs de l'infectivite des retro-virus et produits anti-infectants
US5013545A (en) * 1987-12-09 1991-05-07 Thames Pharmacal Co., Inc. Aqueous gels containing topical medicaments
US5098717A (en) * 1987-12-09 1992-03-24 Thames Pharmacal Co., Inc. Method of treatment for pruritus
CA1337329C (en) * 1989-01-31 1995-10-17 Paul L. Simmons Biodegradable disinfectant
US4923875A (en) * 1989-07-10 1990-05-08 Baker Cummins Pharmaceuticals, Inc. Method for treatment of mast cell-mediated dermatologic disorders
US5331012A (en) * 1990-07-30 1994-07-19 Riddick Kenneth B Topical pharmaceutical preparation for fever blisters and other viral infections and method of use
SE9003712L (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner
JPH07501045A (ja) * 1991-06-20 1995-02-02 セプ、ホールディングス、インコーポレーテッド ヘルペスによる病変部の治癒を促進する局所用組成物
US5376366A (en) 1992-11-12 1994-12-27 John Petchul Composition and process for forming isopropyl alcohol gel with water-soluble vinyl polymer neutralizing agent
PT751789E (pt) * 1994-03-21 2002-04-29 Aase Brown Thomsen Gel para o tratamento de doencas da pele e para desinfeccao da pele
US5665751A (en) * 1995-06-07 1997-09-09 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers

Also Published As

Publication number Publication date
US5981605A (en) 1999-11-09
PT751789E (pt) 2002-04-29
NZ283135A (en) 2004-12-24
CA2186045A1 (en) 1995-09-28
ATE208212T1 (de) 2001-11-15
MX9604208A (es) 1998-05-31
AU701872B2 (en) 1999-02-11
SK119496A3 (en) 1997-06-04
DE69523745D1 (de) 2001-12-13
LV12951B (en) 2003-05-20
RU2142273C1 (ru) 1999-12-10
HU9602583D0 (en) 1996-11-28
CZ272396A3 (en) 1997-06-11
US20040054015A1 (en) 2004-03-18
CZ286758B6 (en) 2000-06-14
FI963696A0 (fi) 1996-09-18
HUP9774641A2 (en) 1997-01-28
JPH09510468A (ja) 1997-10-21
PL316651A1 (en) 1997-02-03
DE69523745T2 (de) 2002-08-08
EE03293B1 (et) 2000-10-16
BR9507164A (pt) 1997-09-09
NO314126B1 (no) 2003-02-03
FI963696A (fi) 1996-11-07
KR100396278B1 (ko) 2003-11-28
ES2168111T3 (es) 2002-06-01
JP3560977B2 (ja) 2004-09-02
EP0751789A1 (en) 1997-01-08
SK281575B6 (sk) 2001-05-10
CZ288150B6 (en) 2001-05-16
US20020086905A1 (en) 2002-07-04
DK0751789T3 (da) 2003-09-08
US6342537B1 (en) 2002-01-29
NO963971L (no) 1996-11-19
CN1146725A (zh) 1997-04-02
UA41989C2 (uk) 2001-10-15
AU2109995A (en) 1995-10-09
PL179918B1 (pl) 2000-11-30
WO1995025544A1 (en) 1995-09-28
EP0751789B1 (en) 2001-11-07

Similar Documents

Publication Publication Date Title
NO963971D0 (no) Gel for behandling av hudsykdommer og for desinfisering av huden
CY1105125T1 (el) Χρηση αναστολεων ακετυλοχολινεστepασης για την παρασκευη φαρμακευτικων συνθεσεων για τη θepαπευτικη αντιμετωπιση συνδρομων λειτουργικων και/ή οργανικων πονων
ATE207342T1 (de) Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
CY1111912T1 (el) Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων
FI970747A (fi) Yhdistelmävalmiste käytettäväksi immunologisissa sairauksissa
KR930702000A (ko) 노년기 치매, 식용항진, 편두통, 또는 식용불량의 치료를 위한 파로세틴의 사용
PL323490A1 (en) Tetralinic compounds exibiting acitity against multgiple-drug refractoriness
ES2148469T3 (es) N-hidroxipiperidinas como agentes de barrido de radicales superoxido.
HK1037980A1 (en) Use of selegiline or desmethylselegiline for the manufacture of a medicament for treating wounds, burns or photodamage.
TR200100637T2 (tr) Yeni doğal ürün türevleri
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
HUP9900007A2 (hu) Készítmény baromfialom kezelésére
DE69103773D1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
DE69424679T2 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ATE137967T1 (de) Verwendung von ketorolac zur behandlung von periodontitis
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
NO962221L (no) Anvendelse av dimeticon for behandling av konstipasjon
HUP0101602A2 (hu) Termékenységet javító készítmény, és annak alkalmazása
HUP9800715A2 (hu) Seb- és nyálkahártya-antiszeptikum
NO20002577L (no) Anvendelse av Escherichia coli-stammen DSM 6601 for behandling av diaré innen veterinærsektoren
KR970019821A (ko) 송진을 함유한 치약 제조 방법
MX9504265A (es) Formulaciones farmaceuticas a partir de rhizophora mangle l.